Analysen von Matthew Weston

24.09.25		Novartis Neutral	UBS AG
23.09.25		Novartis Neutral	UBS AG
23.09.25		Novo Nordisk Neutral	UBS AG
18.09.25		Novo Nordisk Neutral	UBS AG
16.09.25		Novo Nordisk Neutral	UBS AG
15.09.25		Novo Nordisk Neutral	UBS AG
12.09.25		Novartis Neutral	UBS AG
10.09.25		Novo Nordisk Neutral	UBS AG
Werbung
08.09.25		Novo Nordisk Neutral	UBS AG
05.09.25		Novartis Neutral	UBS AG
05.09.25		Novo Nordisk Neutral	UBS AG
01.09.25		Novo Nordisk Neutral	UBS AG
29.08.25		Novo Nordisk Neutral	UBS AG
29.08.25		Novartis Neutral	UBS AG
22.08.25		Novartis Neutral	UBS AG
19.08.25		Novo Nordisk Neutral	UBS AG
14.08.25		Bayer Neutral	UBS AG
12.08.25		Novo Nordisk Neutral	UBS AG
06.08.25		Bayer Neutral	UBS AG
06.08.25		Novo Nordisk Neutral	UBS AG
05.08.25		Novo Nordisk Neutral	UBS AG
22.07.25		Sartorius vz. Neutral	UBS AG
03.07.25		Novartis Neutral	UBS AG
16.06.25		Novartis Neutral	UBS AG
06.06.25		Sartorius Stedim Biotech Neutral	UBS AG
29.04.25		Novartis Neutral	UBS AG
17.04.25		Sartorius vz. Neutral	UBS AG
16.04.25		Sartorius vz. Neutral	UBS AG
10.04.25		Novartis Neutral	UBS AG
09.04.25		Novartis Neutral	UBS AG
13.02.25		Novartis Neutral	UBS AG
06.02.25		AstraZeneca Neutral	UBS AG
31.01.25		Roche Neutral	UBS AG
30.01.25		AstraZeneca Neutral	UBS AG
30.01.25		Roche Neutral	UBS AG
29.01.25		Sartorius Stedim Biotech Neutral	UBS AG
29.01.25		Sartorius vz. Neutral	UBS AG
28.01.25		Sartorius vz. Neutral	UBS AG
28.01.25		Roche Neutral	UBS AG
24.01.25		Sartorius Stedim Biotech Neutral	UBS AG
23.01.25		Sartorius vz. Neutral	UBS AG
20.11.24		AstraZeneca Neutral	UBS AG
13.11.24		Roche Neutral	UBS AG
30.10.24		Roche Neutral	UBS AG
23.10.24		Roche Neutral	UBS AG
22.10.24		Sartorius Stedim Biotech Neutral	UBS AG
22.10.24		Sartorius vz. Neutral	UBS AG
17.10.24		Sartorius vz. Neutral	UBS AG
03.10.24		Sartorius Stedim Biotech Neutral	UBS AG
03.10.24		Sartorius vz. Neutral	UBS AG